Pharmacological treatment of anorexia nervosa: A retrospective study in preadolescents and adolescents

Clinical Pediatrics

Volumn 46, Issue 9, 2007, Pages 806-811

  Rossi, G ^a,d   Balottin, U ^b   Rossi, M ^a   Chiappedi, M ^a,c   Fazzi, E ^a   Lanzi, G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Adolescence; Anorexia nervosa; Pharmacotherapy

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CITALOPRAM; FLUOXETINE; HALOPERIDOL; MIRTAZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; AGGRESSIVENESS; ANOREXIA NERVOSA; ANXIETY DISORDER; ARTICLE; BULIMIA; CHILD; CLINICAL ARTICLE; DEPRESSION; DROWSINESS; EATING DISORDER; FEEDING BEHAVIOR; FEMALE; GASTROENTERITIS; HUMAN; MALE; OBSESSION; RETROSPECTIVE STUDY; SIDE EFFECT; SLEEP DISORDER; TACHYCARDIA; THOUGHT DISORDER; WITHDRAWAL SYNDROME;

ADOLESCENT; ANOREXIA NERVOSA; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CHILD; FEMALE; HUMANS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 35048828784     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922807303929     Document Type: Article

References (36)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4 th ed revised. Washington, DC: American Psychiatric Association ; 2002.
2. Sullivan PF Mortality in anorexia nervosa. Am J Psychiatry. 1995 ; 152: 1073-1074.
3. Keel PK, Dorer DJ, Eddy KT, et al. Predictors of mortality in eating disorders. Arch Gen Psychiatry. 2003 ; 60: 179-183.
4. Stunkard A. Eating disorders: the last 25 years. Appetite. 1997 ; 29: 181-190.
5. Steinhausen HC The outcome of anorexia nervosa in the 20th century. Am J Psychiatry. 2002 ; 159: 1284-1293.
6. Powers PS, Santana C. Available pharmacological treatments for anorexia nervosa. Expert Opin Pharmacother. 2004 ; 5: 2287-2292.
7. Israel M. What is the role of pharmacotherapy in the treatment of anorexia nervosa? J Psychiatry Neurosci. 2005 ; 30: 464.
8. Attia E., Schroeder L. Pharmacological treatment of anorexia nervosa: where do we go from here? Int J Eat Disord. 2005 ; 37 Suppl: S60-63 ; discussion S87-89.
9. Holtkamp K., Konrad K., Kaiser N., et al. A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy. J Psychiatr Res. 2005 ; 39: 303-310.
10. Guy W. ECDEU Assessment Manual for Psychopharmacology. Revised. Rockville, MD: National Institute of Mental Health ; 1976.
11. Schimmelmann BG, Paulus S., Schacht M., et al. Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics. J Child Adolesc Psychopharmacol. 2005 ; 15: 249-258.
12. Pavuluri MN, Henry DB, Carbray JA, et al. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial. Bipolar Disord. 2005 ; 7: 266-273.
13. Schooler N., Rabinowitz J., Davidson M., et al. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry. 2005 ; 162: 947-953.
14. Kapur S., Arenovich T., Agid O., et al. Evidence for onset of antipsychotic effects within the first 24 hours of treatment. Am J Psychiatry. 2005 ; 162: 939-946.
15. Kaye WH, Weltzin TE, Hsu G., et al. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry. 1991 ; 52: 464-471.
16. Kaye WH, Weltzin TE, Hsu G., et al. Relapse Prevention With Fluoxetine in Anorexia Nervosa: A Double-Blind Placebo-controlled Study. Washington, DC: American Psychiatric Association ; 1997: 178.
17. Godart NT, Perdereau F., Jeammet P., Flament MF Comorbidity between eating disorders and mood disorders: review. Encephale. 2005 ; 31 (5 Pt1). 575-587.
18. Pollice C., Kaye WH, Greeno CG, et al. Relationship of depression, anxiety, and obsessionality to state of illness in anorexia nervosa. Int J Eat Disord. 1997 ; 21: 367-376.
19. Lacey JH, Crisp AH Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J. 1980 ; 56 (Suppl 1). 79-85.
20. Biederman J., Herzog DB, Rivinus TM, et al. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol. 1985 ; 5: 10-16.
21. Halmi KA, Eckert ED, LaDu TJ, et al. Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry. 1986 ; 43: 177-181.
22. Attia E., Haiman C., Walsh BT, et al. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry. 1998 ; 155: 548-551.
23. Kaye W., Gendall K., Strober M. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biol Psychiatry. 1998 ; 44: 825-838.
24. Gross HA, Ebert MH, Faden VB, et al. A double-blind controlled trial of lithium carbonate in primary anorexia nervosa. J Clin Psychopharmacol. 1981 ; 1: 376-381.
25. Dally P., Sargant W. A new treatment of anorexia nervosa. Br Med J. 1960 ; 1: 1770-1773.
26. Vandereycken W., Pierloot R. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. Acta Psychiatr Scand. 1982 ; 66: 445-450.
27. Vandereycken W. Neuroleptics in the short-term treatment of anorexia nervosa: a double-blind placebo-controlled study with sulpiride. Br J Psychiatry. 1984 ; 144: 288-292.
28. Hansen L. Olanzapine in the treatement of anorexia nervosa. Br J Psychiatry. 1999 ; 175: 592.
29. La Via MC, Gray N., Kaye WH Case reports of olanzapine treatment of anorexia nervosa. Int J Eat Disord. 2000 ; 27: 363-366.
30. Jensen VS, Mejlhede A. Anorexia nervosa: treatment with olanzapine. Br J Psychiatry. 2000 ; 177: 87.
31. Mondraty N., Birmingham CL, Touyz S., et al. Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australas Psychiatry. 2002 ; 10: 115-124.
32. Södersten P., Bergh C., Ammar A. Anorexia nervosa: towards a neurobiologically based therapy. Eur J Pharmacol. 2003 ; 480: 67-74.
33. Bergh C., Ejderhamn J., Södersten P. What is the evidence basis for existing treatments of eating disorders? Curr Opin Pediatr. 2003 ; 15: 344-345.
34. Janicak PG, Davis JM, Preskorn SH, Ayd FJ Principles and Practice of Psychopharmacotherapy. 3 rd ed. Baltimore, MD: Lippincott Williams & Wilkins ; 2001.
35. Umeki S. Biochemical abnormalities of the serum in anorexia nervosa. J Nerv Ment Dis. 1998 ; 176: 503-506.
36. Ebeling H., Tapanainen P., Joutsenoja A., et al. A practice guideline for treatment of eating disorders in children and adolescents. Ann Med. 2003 ; 35: 488-501.